Chattem forecast
This article was originally published in The Rose Sheet
Executive Summary
Firm raises its FY 2007 earnings-per-share guidance to $2.94 to $3.19; the adjustment anticipates sales growth from the five brands acquired from Johnson & Johnson in January. "We're still launching these new products, and small moves in sales can result in big moves in profitability," President and COO Robert Bosworth said at the SunTrust Robinson Humphrey Institutional Conference April 10. Advertising for the new brands, which began in February, is showing "strong responses," the exec said. Shipping and distribution of the brands were assimilated into the firm in April. For the remainder of FY 2007 and into FY 2008, new products and packaging will be introduced, and the manufacturing of lotions, creams and ointments will be brought in-house, Bosworth said...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.